American Medical News examines PEPFAR five-year strategy

NewsGuard 100/100 Score

American Medical News examines the future of PEPFAR, as outlined in a five-year strategy released Dec. 1. "The plan's five-year strategy report calls for strengthening other countries' abilities to lead [a] response to the AIDS epidemic and other health issues, and expanding prevention, care and treatment," the news service writes. "It also seeks to integrate and coordinate HIV/AIDS programs with broader global health and development programs to maximize the impact on health systems, and invest in innovation and operations research to improve patient care and provide the best outcomes."

"The global AIDS emergency is not over. Countries still struggle with vast unmet needs. There are an estimated 33.4 million people [worldwide] living with HIV and an estimated 2.7 million who have come in with new infections each year, with about 2 million deaths," Ambassador Eric Goosby, U.S. global AIDS coordinator, said during a town hall at the Kaiser Family Foundation on Dec. 4. He continued, "If we are to sustain the gains we've made against this epidemic, PEPFAR must work in closer collaboration with country governments to support them in taking the lead in planning a response to their epidemics and orchestrating outside resources."

The article highlights additional targets outlined in the five-year strategy and provides some background on the history and achievements of PEPFAR since it was authorized by Congress and President George W. Bush in 2003 (Henry, 12/23).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication